Loomis AB has, through its subsidiary Loomis International Corporate AG, entered into an agreement to acquire 100 percent of Kipfer-Logistik GmbH.

Kipfer-Logistik is a logistics company based in Switzerland, which specializes in temperature-controlled transport and storage in the pharmaceutical and healthcare sectors. The company had revenues of approximately CHF 9 million (SEK 108 million) in 2024 and has 28 employees.

Loomis has been offering the transportation of pharmaceutical products in temperature-controlled environments on a smaller scale in Switzerland since 2024 under the brand of Loomis Pharma. The acquired business will be reported in the International business line within Segment Europe and Latin America and consolidated into Loomis as of closing of the transaction. The acquisition is expected to be completed on September 1, 2025, subject to certain conditions.

"This acquisition accelerates the growth of Loomis Pharma by integrating a well-established Swiss logistics company specializing in high-security and temperature-controlled road freight transport. Together, we will provide our customers with an even more comprehensive range of services, thereby strengthening our market position," says Aritz Larrea, President and CEO of Loomis.  

The acquisition is expected to be accretive to the Group's operating profit (EBITA1) and the earnings per share for 2025.

1) Earnings Before Interest, Taxes, Amortization of acquisition-related intangible fixed assets, Acquisition-related costs and revenue and items affecting comparability.  

This press release is also available on the company's website, www.loomis.com.

For more information, please contact:

Jenny Boström

Head of Sustainability and IR

jenny.bostrom@loomis.com

+46 79 006 45 92